Last reviewed · How we verify
NCT05235763: HEALTHY
Heart Failure Activity Coach Study
NA trial testing activity coach in Physical Inactivity in 20 participants. Completed in 1 September 2023.
30 July 2023
Quick facts
| Lead sponsor | CareLigo AB |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 1 June 2022 |
| Primary completion | 30 July 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- activity coach
- sham activity coach
Conditions studied
- Physical Inactivity — all drugs for Physical Inactivity →
- Heart Failure — all drugs for Heart Failure →
Sponsor
CareLigo AB
Who can join
18 and older, any sex, with Physical Inactivity or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An application (app) called the activity coach will be tested to see if it can increase physical activity and decrease sedentary behaviuor, as well as increase quality of life and lead to personal goal attainment in physically inactive heart failure (HF) patients. This pilot randomized controlled trial (RCT) will test the study design and recruitment process, as well as outcomes for a future efficacy RCT. HF-patients equipped with the mHealth-tool Optilogg will be screened for physical inactivity and then recruited and randomized to either have the activity coach app added to their Optilogg or remain with the standard Optilogg. The study will go on for 12 weeks. Weeks 1 and 12 physical activity using an accelerometer will be recorded, as well as health-related quality of life. At the start of the study the patients will list goals relating to physical activity which the wish to attain, and the level of attainment will be evaluated at the end of the study. The activity coach educated the patient about physical activity, offers means of manually tracking physical activity, and provides trends of registered activity. Furthermore, it provides weekly summaries of registered physical activity and provides means of setting goals for the following week.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Testing the Recruitment Frequency, Implementation Fidelity, and Feasibility of Outcomes of the Heart Failure Activity Coach Study (HEALTHY): Pilot Randomized Controlled Trial.
Blomqvist A, Bäck M, Klompstra L, Strömberg A, et al · · 2025 · cited 4× · PMID 39778202 · DOI 10.2196/62910 -
Usability and feasibility analysis of an mHealth-tool for supporting physical activity in people with heart failure.
Blomqvist A, Bäck M, Klompstra L, Strömberg A, et al · · 2024 · cited 3× · PMID 38347499 · DOI 10.1186/s12911-024-02452-z -
Exploring user experience: A qualitative analysis of the use of a physical activity support app for people with heart failure.
Blomqvist A, Strömberg A, Lundberg M, Bäck M, et al · · 2025 · cited 1× · PMID 40402948 · DOI 10.1371/journal.pone.0309577
Verify or expand the search:
- PubMed search for NCT05235763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physical Inactivity
Currently open trials in the same condition.
- NCT07427329 — Benefits of Physical Activity During the School Day to Reduce Mental Fatigue and Optimize Cognitive and Psychosocial Pro · NA · active not recruiting
- NCT07128095 — COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise · recruiting
- NCT07380750 — Active Families, Healthy Minds: A Family-Centered School Physical Activity Program for Early Adolescents · NA · active not recruiting
- NCT06386055 — Air Pollution and Physical Activity Study · NA · recruiting
- NCT07043920 — Impact of Smoking on Physical Activity Level in Young Adults · recruiting
Other CareLigo AB trials
Trials by the same sponsor.
- NCT03655496 — Patient-centred Home-based Management of Heart Failure · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05235763 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CareLigo AB
- Last refreshed: 24 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05235763.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing